Sort
51,593 grants matching “hepatitis”
Dysregulated neutrophil subpopulations as a driving mechanism of liver and gastrointestinal disease in HIV-1-infected individuals
$734,114Zdenek Hel · University Of Alabama At Birmingham · R01 · FY2025 · DK
Gluconeogenesis and Glycogenolysis - Role and Regulation
$734,103Alan D Cherrington · Vanderbilt University · R01 · FY2009 · DK
Effects of Hepatic Acetyl-CoA Carboxylase Inhibition on NAFLD and Hepatic Insulin Resistance
$733,997Gerald I Shulman · Yale University · R01 · FY2018 · DK
Effects of Hepatic Acetyl-CoA Carboxylase Inhibition on NAFLD and Hepatic Insulin Resistance
$733,997Gerald I Shulman · Yale University · R01 · FY2017 · DK
Pan-Genomic Approaches for Comprehensive Blood Screening of Novel or Emerging Infectious Agents
$733,979Charles Yen Chiu · University Of California, San Francisco · R01 · FY2017 · HL
Sex-Specific Risk of Metabolic and Cardiovascular Disease
$733,978John Micheal Stafford · Vanderbilt University Medical Center · R01 · FY2025 · HL
Alimentary Tract Lipids in Health and Disease
$733,959Brigham And Women'S Hospital · R37 · FY2005 · DK
Rural Comorbidity and HIV consequences of Opioid use Research and Treatment Initiative (Rural cohort)
$733,846Heidi M. Crane · University Of Washington · U24 · FY2023 · DA
Oxytocin as a Neuroendocrine Therapy for Obesity in Youth
$733,817Elizabeth Austen Lawson · Massachusetts General Hospital · R01 · FY2020 · DK
Therapy of transplantation-induced oxidative injury using polymeric antioxidants
$733,811Michael W Fanger · Celdara Medical, Llc · R44 · FY2016 · DK
Automated quantification of lipid droplets in fatty liver tissue sections
$733,790Patrick M McDonough · Vala Sciences, Inc. · R42 · FY2011 · DK
Estrogen Administration for the Treatment of NASH in Postmenopausal Women
$733,668Karen K Miller · Massachusetts General Hospital · R01 · FY2021 · DK
Estrogen Administration for the Treatment of NASH in Postmenopausal Women
$733,668Karen K Miller · Massachusetts General Hospital · R01 · FY2025 · DK
Estrogen Administration for the Treatment of NASH in Postmenopausal Women
$733,668Karen K Miller · Massachusetts General Hospital · R01 · FY2022 · DK
Estrogen Administration for the Treatment of NASH in Postmenopausal Women
$733,668Karen K Miller · Massachusetts General Hospital · R01 · FY2023 · DK
A geospatial analysis of hotspots and targeted injection settings pilot intervention for HIV prevention among people who inject drugs in Baltimore, Maryland
$733,662Carl A Latkin · Johns Hopkins University · R01 · FY2024 · DA
RACIAL DIFFERENCE IN HCV/HOST INTERACTIONS
$733,604University Of Tennessee Health Sci Ctr · U19 · FY2000 · AI
HIV HCV Coinfection Antiviral Therapy and Fibrosis
$733,577David L Thomas · Johns Hopkins University · R37 · FY2015 · DA
HIV HCV Coinfection Antiviral Therapy and Fibrosis
$733,577David L Thomas · Johns Hopkins University · R37 · FY2019 · DA
HIV HCV Coinfection Antiviral Therapy and Fibrosis
$733,577David L Thomas · Johns Hopkins University · R37 · FY2017 · DA
Blocking Arsenicals-induced Cutaneous Injury
$733,530Mohammad Athar · University Of Alabama At Birmingham · U01 · FY2017 · NS
Blocking Arsenicals-induced Cutaneous Injury
$733,530Mohammad Athar · University Of Alabama At Birmingham · U01 · FY2016 · NS
Blocking Arsenicals-induced Cutaneous Injury
$733,530Mohammad Athar · University Of Alabama At Birmingham · U01 · FY2015 · NS
Blocking Arsenicals-induced Cutaneous Injury
$733,530Mohammad Athar · University Of Alabama At Birmingham · U01 · FY2019 · NS
Pathogenesis of youth onset pre-diabetes and Type 2 diabetes
$733,481Sonia Caprio · Yale University · R01 · FY2024 · DK